Key facts
- PointCaré’s last known valuation is $4.1M (Jun 2025).
- It has raised $1.6M; the latest was Angel (individual) ($1.6M) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for PointCaré
- ·The full record, as it builds
Funding rounds
No funding rounds for PointCaré are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PointCaré
Developer of AI-powered clinical decision support tools intended to improve safety, personalization, and cost efficiency in critical care. The company's platform integrates real-time data streams from various medical devices with contextual interpretation and explainable AI, enabling hospitals and intensive care units to enhance situational awareness and make more accurate, patient-specific decisions.
- Sector
- Healthcare
- HQ
- Gent, Belgium
- Founded
- 2022
- Employees
- 4
- Website
- pointcare.be/
- Ownership
- Privately Held (backing)
PointCaré doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PointCaré shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PointCaré in its N-PORT filings yet. We sweep new filings monthly.